NAUT Nautilus Biotechnology: Company Long-Term Indebtedness

Corporate company logo of nautilus.bio (NAUT)

Nautilus Biotechnology (NAUT) derives its competitive advantage from patents on precision proteome mapping, which create a barrier for traditional biotech. The company aims to capture the digital DNA niche by expanding its IT solutions into research centers. The price action of the securities with the 0.02 indicator complements data on a business that integrates AI and nanotechnology to sell intellectual software without maintaining its own production.

NAUT Nautilus Biotechnology, Inc. Company Long-Term Liabilities (07/04/2022 - 10/29/2026)

Analytical breakdowns for Nautilus Bio (NAUT)

- price and consensus price forecast:
Stock Price Nautilus Biotechnology, Inc.|NAUT - Price Target Chart
- market capitalization data:
Market Capitalization Nautilus Biotechnology|NAUT - Enterprise Value
- book capitalization data:
Book Value per Share Nautilus Biotechnology|NAUT - Company Net Assets|Market Capitalization to Book Value Ratio nautilus.bio|NAUT - Cumulative Company Assets
- debt and liquidity data:
Aggregate Debt to Capital Nautilus Biotechnology|NAUT - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Nautilus Biotechnology, Inc.|NAUT - Company Debts|Debt to Book Capitalization Ratio Nautilus Biotechnology|NAUT - Company Long-Term Liabilities|Company Short-Term Debts Nautilus Biotechnology
Analysis of all company metrics:NAUT - Nautilus Biotechnology
Original product of Nautilus Biotechnology

For a portfolio analyst, identifying fundamental leaders requires evaluating long-term liabilities as a measure of financial leverage and capital structure stability. This indicator captures the volume of borrowed funds with maturities exceeding one year, which, in the context of the development of the Nautilus Biotechnology (NAUT) AI proteomics platform, reflects investments in creating a technological moat, while an analysis of the firm's long-term debt on GURU.Markets allows for an assessment of debt load risk.

Who Nautilus Biotechnology competes with

Tempus Labs - Company Long-Term Debts|Qiagen (QGEN) - Company Long-Term Debt|IONS - Company Long-Term Indebtedness|RGEN: Company Long-Term Debts|Company Long-Term Debts Avidity Corp|CRSP (CRISPR Therapeutics AG) - Company Long-Term Liabilities|Company Long-Term Debts genedx.com (WGS)|Company Long-Term Liabilities Ultragenyx|Amount of Long-Term Liabilities Beam Therapeutics Inc (BEAM)|Company Long-Term Debts SRPT|Twist Bioscience Corp - Long-Term Debt Volume|TXG - Company Long-Term Debt|intelliatx.com (NTLA) - Company Long-Term Debt|STOK: Company Long-Term Liabilities|BLFS (BioLife Solutions Inc) - Company Long-Term Debts|WVE: Company Long-Term Debt|Long-Term Debt Volume Maze Therapeutics Corp (MAZE)|Sionna Therapeutics Inc (SION) - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings primemedicine.com (PRME)|Company Long-Term Debts Taysha Gene Therapies, Inc. TSHA|Company Long-Term Debt uniQure NV QURE|Company Long-Term Debts MGTX (MeiraGTx PLC)|RGNX: Long-Term Debt Volume|Company Long-Term Debt SLDB|Long-Term Debt ocugen.com|PacBio (PACB) - Company Long-Term Liabilities|Amount of Long-Term Liabilities Benitec Biopharma Inc|Design Pharma - Company Long-Term Debts|Long-Term Debt Rocket Corp (RCKT)|4D Molecular Therapeutics - Company Long-Term Debts|Company Long-Term Liabilities Lexeo Therapeutics Inc. LXEO|Company Long-Term Debts Korro Bio, Inc (KRRO)|EDIT: Company Long-Term Loans and Borrowings|Company Long-Term Debt Silence Therapeutics Inc.|PRQR (ProQR Therapeutics) - Company Long-Term Indebtedness|Company Long-Term Debt CDXS (Codexis Inc)|Long-Term Debt SGMO|Company Long-Term Debt Metagenomi (MGX)|Company Long-Term Debt DTIL (Precision BioSciences Inc.)|GBIO: Company Long-Term Debt|Long-Term Debt Boundless Bio Inc BOLD|Company Long-Term Debts XCUR|Imunon, Inc. (IMNN) - Long-Term Indebtedness|Company Long-Term Liabilities PHIO|MBIO (Mustang Bio) - Long-Term Debt|Company Long-Term Debt TransCode Therapeutics Inc. (RNAZ)|Company Long-Term Indebtedness Bionano|Company Long-Term Debts APDN|Company Long-Term Debts bluebirdbio.com BLUE|Company Long-Term Liabilities IPA (ImmunoPrecise Antibodies Ltd.)|OMGA - Company Long-Term Debts|Company Long-Term Liabilities Singular Genomics Systems Inc OMIC|RGLS - Amount of Long-Term Liabilities|Company Long-Term Debts Syros Pharmaceuticals|TBIO (telesisbio.com) - Company Long-Term Indebtedness|Company Long-Term Debt TRACON Pharmaceuticals, Inc. (TCON)|Company Long-Term Indebtedness Unity Biotechnology Inc.